Landos Biopharma, Inc.

Pharmaceutical Preparations·BLACKSBURG, VA

Landos is a commune in the Haute-Loire department in south-central France.

Financials

15 shown

Type	Period	Ended	Filed
10-Q	Q1 2024	3/31/24	5/9/24	→
10-K/A	FY 2023	12/31/23	4/16/24	→
10-K	FY 2023	12/31/23	3/21/24	→
10-Q	Q3 2023	9/30/23	11/9/23	→
10-Q	Q2 2023	6/30/23	8/9/23	→
10-Q	Q1 2023	3/31/23	5/12/23	→
↓

Earnings Releases (8-K)

13 shown

Filed	Period
3/21/24	Q1 FY2024	→
11/9/23	Q4 FY2023	→
8/9/23	Q3 FY2023	→
5/12/23	Q2 FY2023	→
3/23/23	Q1 FY2023	→
11/10/22	Q4 FY2022	→
↓

News (8-K)

40 shown

Filed	Type	Description
5/23/24	Delisting	Completion of Acquisition or Disposition of Assets	→
5/23/24	Vote	Submission of Matters to a Vote of Security Holders	→
3/25/24	Agreement	Entry into a Material Definitive Agreement	→
1/4/24	Reg FD	Regulation FD Disclosure	→
11/21/23	Reg FD	Regulation FD Disclosure	→
9/21/23	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

15 shown

Filed	Form	Description
5/23/24	S-8 POS	S-8 POS	→
5/23/24	S-8 POS	S-8 POS	→
5/23/24	S-8 POS	S-8 POS	→
5/23/24	S-8 POS	S-8 POS	→
3/21/24	S-8	S-8	→
4/19/23	ARS	ARS	→
↓

Filing History(211 filings)

TypeDateAccessionPeriodSize

15-12G

Jun 3, 2024

0001193125-24-15228915-12G

—

10.9 KB

May 23, 2024

0001415889-24-014342

May 23, 2024

8.2 KB

May 23, 2024

0001415889-24-014341

May 23, 2024

10.2 KB

May 23, 2024

0001415889-24-014340

May 23, 2024

10.3 KB

May 23, 2024

0001415889-24-014338

May 23, 2024

6.2 KB

May 23, 2024

0001415889-24-014337

May 23, 2024

10.3 KB

May 23, 2024

0001415889-24-014336

May 23, 2024

10.3 KB

May 23, 2024

0001415889-24-014335

May 23, 2024

11.3 KB

May 23, 2024

0001415889-24-014334

May 23, 2024

11.3 KB

May 23, 2024

0001193125-24-146069RW

—

7.6 KB

S-8 POS

May 23, 2024

0001193125-24-146059S-8 POS

—

23.1 KB

S-8 POS

May 23, 2024

0001193125-24-146054S-8 POS

—

23.1 KB

S-8 POS

May 23, 2024

0001193125-24-146051S-8 POS

—

23.1 KB

S-8 POS

May 23, 2024

0001193125-24-146048S-8 POS

—

23.1 KB

8-K

May 23, 2024

0001193125-24-1460148-K

May 23, 2024

279.2 KB

25-NSE

May 23, 2024

0001354457-24-000356

—

2.9 KB

8-K

May 23, 2024

0001193125-24-1456858-K

May 23, 2024

146.7 KB

10-Q

May 9, 2024

0000950170-24-05631110-Q

Mar 31, 2024

3.9 MB

DEFM14A

Apr 25, 2024

0001193125-24-114268DEFM14A

—

2.6 MB

10-K/A

Apr 16, 2024

0001193125-24-09702310-K/A

Dec 31, 2023

672.3 KB

PREM14A

Apr 15, 2024

0001193125-24-096376PREM14A

Apr 15, 2024

2.7 MB

SC 13D/A

Apr 10, 2024

0001193125-24-091998SC 13D/A

—

89.0 KB

SC 13D/A

Apr 10, 2024

0001193125-24-091996SC 13D/A

—

32.3 KB

DEFA14A

Mar 26, 2024

0001193125-24-077190DEFA14A

—

52.4 KB

DEFA14A

Mar 25, 2024

0001193125-24-076461DEFA14A

—

1.3 MB

25 filings shown

Landos Biopharma, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(211 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/25/24	DEFM14A	DEFM14A	→
4/15/24	PREM14A	PREM14A	→
3/26/24	DEFA14A	DEFA14A	→
3/25/24	DEFA14A	DEFA14A	→
3/25/24	DEFA14A	DEFA14A	→
4/19/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
6/3/24	15-12G	15-12G	→
5/23/24	RW	RW	→
5/23/24	25-NSE	25-NSE	→
8/15/22	EFFECT	EFFECT	→
2/3/21	EFFECT	EFFECT	→
2/2/21	CERT	CERT	→
↓